SAMUEL ALTHAUSER: Open Payments
NPI 1306224050 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 46 payments from 15 companies in 2025. Trend: 2023 $228 · 2024 $413 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $263 |
| Brainsway USA INC | 1 | $136 |
| Teva Pharmaceuticals USA, Inc. | 3 | $83 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Alkermes, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $28 |
Products named: VRAYLAR, deep tms, AUSTEDO XR, COBENFY, Sunosi, INGREZZA, CAPLYTA, FANAPT.
Industry payments across CA — which companies pay providers there.
